Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim Guidelines on Antiviral Therapy for COVID-19.
Kim SB, Huh K, Heo JY, Joo EJ, Kim YJ, Choi WS, Kim YJ, Seo YB, Yoon YK, Ku NS, Jeong SJ, Kim SH, Peck KR, Yeom JS. Kim SB, et al. Among authors: joo ej. Infect Chemother. 2020 Jun;52(2):281-304. doi: 10.3947/ic.2020.52.2.281. Epub 2020 Apr 23. Infect Chemother. 2020. PMID: 32342676 Free PMC article. Review.
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study.
Joo EJ, Ko JH, Kim SE, Kang SJ, Baek JH, Heo EY, Shi HJ, Eom JS, Choe PG, Bae S, Ra SH, Kim DY, Kim BN, Kang YM, Kim JY, Chung JW, Chang HH, Bae S, Cheon S, Park Y, Choi H, Lee E, Lee BY, Park JW, Sohn Y, Heo JY, Kim SH, Peck KR. Joo EJ, et al. J Korean Med Sci. 2021 Mar 22;36(11):e83. doi: 10.3346/jkms.2021.36.e83. J Korean Med Sci. 2021. PMID: 33754512 Free PMC article.
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.
Kim SB, Kim J, Huh K, Choi WS, Kim YJ, Joo EJ, Kim YJ, Yoon YK, Heo JY, Seo YB, Jeong SJ, Yu SY, Peck KR, Choi M, Yeom JS; Korean Society of Infectious Diseases (KSID). Kim SB, et al. Among authors: joo ej. Infect Chemother. 2021 Jun;53(2):395-403. doi: 10.3947/ic.2021.0304. Infect Chemother. 2021. PMID: 34216134 Free PMC article.
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19.
Kim SB, Ryoo S, Huh K, Joo EJ, Kim YJ, Choi WS, Kim YJ, Yoon YK, Heo JY, Seo YB, Jeong SJ, Park DA, Yu SY, Lee HJ, Kim J, Jin Y, Park J, Peck KR, Choi M, Yeom JS; Korean Society of Infectious Diseases (KSID). Kim SB, et al. Among authors: joo ej. Infect Chemother. 2021 Mar;53(1):166-219. doi: 10.3947/ic.2021.0303. Infect Chemother. 2021. PMID: 34409790 Free PMC article. Review.
Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea.
Shi HJ, Nham E, Kim B, Joo EJ, Cheong HS, Hong SH, Hyun M, Kim HA, Jang S, Rhee JY, Kim J, Kim S, Cho HK, Wi YM, Cheon S, Kim YS, Lim S, Seok H, Jung SI, Eom JS, Peck KR. Shi HJ, et al. Among authors: joo ej. J Korean Med Sci. 2022 Jun 6;37(22):e175. doi: 10.3346/jkms.2022.37.e175. J Korean Med Sci. 2022. PMID: 35668685 Free PMC article.
188 results